Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil.

The Journal of infectious diseases - 1 May 1999

Pilcher C D, Perkins M D, Fiscus S A, Johnston D M, Dietze R, Duque U H, Zago A M, Assad-Antunes F, Eron J J

Abstract excerpt

Before December 1997, in Espírito Santo, Brazil, combination antiretroviral therapy was used without routine virologic or immunologic monitoring. To examine consequences of therapy in this setting, clinical information, human immunodeficiency virus type 1 (HIV-1) RNA levels, CD4 cell counts, and protease and reverse transcriptase sequences were determined for consecutive HIV-1-infected outpatients. Of 48...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Drug Therapy, Combination

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 10191233
DOI: 10.1086/314709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil.PMID 10191233Read ↗

HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil.Semantic proximity Read ↗

Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results.Semantic proximity Read ↗

Prevalence of Antiretroviral Drug Resistance Mutations in HIV Seropositive Patients from an Outpatient Clinic of a Large University Hospital from São Paulo, Brazil.Semantic proximity Read ↗

Evaluation of the genotypic pattern of HIV-1 resistance in AIDS patients failing antiretroviral therapy.Semantic proximity Read ↗

Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.Semantic proximity Read ↗

Prevalence of HIV type 1 drug resistance mutations in treatment-naïve and experienced patients from resource-limited settings with universal access to antiretroviral therapy: a survey in two small Brazilian cities.Semantic proximity Read ↗

Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.Semantic proximity Read ↗

Frequency and diversity of human immunodeficiency virus type 1 mutations associated with antiretroviral resistance among patients from Southern Brazil failing highly active antiretroviral therapy (HAART).Semantic proximity Read ↗

Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals.Semantic proximity Read ↗

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.Semantic proximity Read ↗

Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.Semantic proximity Read ↗

HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.